BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES (BARI 2D)

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项试验旨在确定初始选择性冠状动脉血运重建术与积极的药物治疗相结合的有效性，以及在控制高血糖方面提供更多胰岛素与增加对胰岛素的敏感性的有效性。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This trial is designed to determine the efficacy of initial elective coronary revascularization combined with aggressive medical therapy, and the efficacy of providing more insulin vs. increasing sensitivity to insulin in the management of hyperglycemia.